Olink News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.06.24	Thermo Fisher Extends Expiration Of Tender Offer For Olink Shares, ADSs - Quick Facts (RTTNews)
01.03.24	Thermo Fisher Extends Acquisition Deadline For Olink Until April 30 (RTTNews)
04.01.24	Thermo Fisher Scientific: Tender Offer For Olink To Expire On Feb. 29 (RTTNews)
21.11.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CNSL, OLK, TGH, CSTR (PR Newswire)
14.11.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLK, TGH, PATI (PR Newswire)
31.10.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLK, FAZE, TGH (PR Newswire)
24.10.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHS, SLGC, ORTX, OLK (PR Newswire)
19.10.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VSTO, OLK, PNT (PR Newswire)
17.10.23	Thermo Fisher Scientific To Acquire Olink For $3.1 Bln (RTTNews)
12.07.23	Announcing Olink® Explore HT – A New Era in Proteomics (GlobeNewswire)
19.01.23	Pre-market Movers: BMEA, GGE, HUDI, STBX, TIRX… (RTTNews)
14.12.22	DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS (PR Newswire)
17.11.22	Maria Martin-Grau, at the University of Valencia, Spain is selected for the 2022 Novelties in Biomarkers award (GlobeNewswire)
14.11.22	Announcing Olink® Flex, a new, unique and fully flexible low-plex proteomics solution using absolute quantification (GlobeNewswire)
03.11.22	Olink announces milestone achievement of 1,000 peer-reviewed articles citing use of PEA technology (GlobeNewswire)
01.11.22	Olink to participate in November investor events (GlobeNewswire)
24.10.22	Announcing Olink® Insight, a digital knowledge-sharing platform to amplify the value of proteomics data (GlobeNewswire)
13.10.22	Olink to report third quarter 2022 financial results on November 10, 2022 (GlobeNewswire)
20.09.22	Discovery Life Sciences partners with Olink to support proteomics research and accelerate precision medicine programs (GlobeNewswire)
20.09.22	DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE (PR Newswire)
15.09.22	Multi-omics service provider Sequanta completes extended concordance validation of Olink® Target 48/96 and Olink® Explore (GlobeNewswire)
31.08.22	Olink strengthens management team for continued leadership in the modern proteomics era (GlobeNewswire)
30.08.22	Olink to participate in September investor conferences (GlobeNewswire)
14.07.22	Olink to report second quarter 2022 financial results on August 11, 2022 (GlobeNewswire)
28.06.22	Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insight (GlobeNewswire)
21.06.22	UK Biobank Pharma Proteomics Project publishes early results from its pioneering proteomics research (GlobeNewswire)
16.06.22	Erasmus Medical Center, Rotterdam is partnering with Olink to deepen understanding of disease progression and accelerate the development of novel therapies (GlobeNewswire)
13.06.22	FinnGen selects Olink to accelerate leading Population Health Study (GlobeNewswire)
08.06.22	Ultima Genomics and Olink collaborate to develop solution for high-throughput proteomics (GlobeNewswire)
08.06.22	Ultima Genomics and Olink collaborate to develop solution for high-throughput proteomics (PR Newswire)
07.06.22	Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read™ sequencing kits (GlobeNewswire)
07.06.22	Element Biosciences and Olink collaborate to enable Olink® Explore on the Element AVITI™ System (GlobeNewswire)
02.06.22	Pharma Foods International and Olink initiate strategic partnership in Japan (GlobeNewswire)
01.06.22	Olink to participate in the 43rd Annual Goldman Sachs Global Healthcare Conference (GlobeNewswire)
12.05.22	Olink reports first quarter 2022 financial results (GlobeNewswire)
09.05.22	University of Oxford adopts Olink technology to advance protein biomarker discovery and unravel mechanisms of disease (GlobeNewswire)
21.04.22	Olink to report first quarter 2022 financial results on May 12, 2022 (GlobeNewswire)
07.04.22	Report from the Annual General Meeting of Olink Holding AB (publ) on 7 April 2022 (GlobeNewswire)
17.03.22	Olink publishes 2021 annual report (GlobeNewswire)
09.03.22	TATAA Biocenter partners with Olink to add high quality proteomics with unrivaled throughput to their multi-omics offering (GlobeNewswire)
07.03.22	Notice to attend the Annual General Meeting of Olink Holding AB (publ) (GlobeNewswire)
07.03.22	THE NOMINATION COMMITTEE’S PROPOSAL FOR ELECTION OF MEMBERS OF THE BOARD OF DIRECTORS OF OLINK HOLDING AB (PUBL) (GlobeNewswire)
01.02.22	Olink to present at February investor conferences (GlobeNewswire)
20.01.22	Sequanta selects Olink® Explore 3072 to analyze new cohort study in China (GlobeNewswire)
10.01.22	Olink announces preliminary unaudited revenue for the fourth quarter and full year 2021 (GlobeNewswire)
04.01.22	Olink to present at the 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
06.12.21	Innovation and transparency at the heart of Olink’s culture – details of the technology behind the Olink Explore high-throughput proteomics platform published in the journal, Molecular & Cellular Prot (GlobeNewswire)
02.12.21	Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failure (GlobeNewswire)
01.12.21	Olink® Explore 3072 high-throughput proteomics platform now available: Significantly expands Olink's protein library for biomarker discovery (GlobeNewswire)
29.11.21	Melissa Amrein, at the University Hospital of Basel, Switzerland, is awarded the 2021 Novelties in Biomarkers prize at the Biomarkers of the Future Conference in Paris, France (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	123.45	1.90 %	K V
Alcon	77.58	1.76 %	K V
Lonza Grp	529.60	0.57 %	K V
Kuehne+Nagel Int	209.80	0.48 %	K V
Logitech Intl	72.44	0.33 %	K V
ABB	49.62	-0.68 %	K V
Sika	229.50	-0.74 %	K V
Roche Hldg G	251.60	-0.75 %	K V
Swisscom	504.00	-0.98 %	K V
UBS Group	28.00	-1.23 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Olink Holding AB (publ) (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten